Skip to content

Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome

Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03444168
Enrollment
158
Registered
2018-02-23
Start date
2018-06-29
Completion date
2023-04-20
Last updated
2026-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Keywords

lumbar spine surgery, lumbar failed back surgery syndrome

Brief summary

The purpose of this study is to learn whether or not certain risk factors and patient characteristics are linked with and possibly can predict the development of chronic pain after lumbar spine surgery.

Interventions

None listed

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER
National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

For All Participants: * Ability to read and speak English to allow for written informed consent, phenotyping, and patient-reported outcomes measures

Exclusion criteria

For All Participants: * Individuals receiving or applying for compensation or disability and other aspects associated with potential secondary gain * Inability to provide written informed consent * Severe physical impairment * Co-morbid medical conditions that may significantly impair physical functional status * Illicit drug or unreported opioid use * Medical or psychiatric conditions that in the judgment of study personnel would preclude participation in this study * Pregnant or nursing * Liver failure * Self-reported liver cirrhosis * Self-reported hepatitis * Severe Cardiovascular disease Inclusion Criteria for Candidates for Lumbar Spine Surgery: * Deemed to be a candidate for primary lumbar spine surgery including but not limited to: lumbar laminectomy, discectomy, and fusion/instrumentation * Diagnostic clinical and radiographic findings including but not limited to: lumbar degenerative disc disease, lumbar disc protrusion, herniation, or extrusion, lumbar spondylosis, lumbar spinal stenosis, lumbar spondylolisthesis or spondylolysis * Willingness to participate in longitudinal follow-up or 6-months after their surgery.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Pain Severity - 50% Reduction Responders vs NonrespondersChange from Baseline to Month 6Measured by the Brief Pain Inventory (BPI). The BPI scores are a numerical rating scale and range from 0 to 10. A score of 0 is equal to no pain and a score of 10 is equal to pain as bad as you can imagine.
Fibromylagia-ness (FMness)Baseline2011 Fibromyalgia Survey score is calculated by combining the widespread pain index (WPI) and the Symptom Severity Scale (SSI) to derive a score from 0-31. Scores greater than or equal to 13 indicate a diagnosis of Fibromyalgia. Higher scores indicate the degree of central sensitization present in a given individual.
PROMIS T-score - Fatigue, Physical Function, Sleep-Related ImpairmentBaselinePROMIS measures to be included are Depression, Anxiety, Physical Functioning, Fatigue, Sleep Impairment, Emotional Support, and Social Participation. Each questionnaire usually has 4-16 response options ranging in value from one to five. The total raw score for a short form with all questions answered is the sum of the values of the response to each question. The total range of potential raw scores depends on the number of questions being asked, for example, a 6 item form would have a range from is 6 to 30. After the raw score is calculated, a T-score metric is used to convert the raw score to a T-score. On the T-score metric, a score of 50 is the mean of a relevant reference population and 10 is the standard deviation of that mean. For PROMIS measures, higher scores equals "more of the concept being measured", this could be a desirable or undesirable outcome, depending on the concept being measured.
PROMIS T-score - Anxiety, Depression, Emotional Support, Pain Interference, Satisfaction With Social RolesBaselinePROMIS measures to be included are Depression, Anxiety, Physical Functioning, Fatigue, Sleep Impairment, Emotional Support, and Social Participation. Each questionnaire usually has 4-16 response options ranging in value from one to five. The total raw score for a short form with all questions answered is the sum of the values of the response to each question. The total range of potential raw scores depends on the number of questions being asked, for example, a 6 item form would have a range from is 6 to 30. After the raw score is calculated, a T-score metric is used to convert the raw score to a T-score. On the T-score metric, a score of 50 is the mean of a relevant reference population and 10 is the standard deviation of that mean. For PROMIS measures, higher scores equals "more of the concept being measured", this could be a desirable or undesirable outcome, depending on the concept being measured.
Oswestry Disability IndexBaselineThe Oswestry Disability Index will be used to assess low back pain. There are 10 sections on the index. Each section has a possible score of 5. The total possible range of scores is 0 to 50. A score of 0 indicates no pain. A score of 50 indicates the person is bed-bound or exaggerating their symptoms.

Secondary

MeasureTime frameDescription
Coping Strategies Questionnaire - CATBaselineA 6-item catastrophizing scale that measures ways to cope or deal with pain. Each item is scored on a scale of 0-6. Scores can range from 0-36, with the higher the score the higher the rate of catastrophizing.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAndrea Chadwick, MD

University of Kansas Medical Center

Baseline characteristics

Characteristic
Age, Continuous54 years
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
137 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race/Ethnicity, Customized
Race
American Indian, Alaskan
0 Participants
Race/Ethnicity, Customized
Race
Asian
0 Participants
Race/Ethnicity, Customized
Race
Black, African American
8 Participants
Race/Ethnicity, Customized
Race
Native Hawaiian or Pacific Islander
0 Participants
Race/Ethnicity, Customized
Race
Other, Unknown
3 Participants
Race/Ethnicity, Customized
Race
White
37 Participants
Sex: Female, Male
Female
32 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
1 / 550 / 400 / 49
other
Total, other adverse events
0 / 550 / 400 / 49
serious
Total, serious adverse events
1 / 550 / 400 / 49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026